Formycon AG

52.30
-0.50 (-0.95%)
At close: Feb 10, 2025, 5:00 PM
undefined%
Bid n/a
Market Cap 923.85M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 4.03
PE Ratio (ttm) 12.98
Forward PE n/a
Analyst n/a
Ask n/a
Volume 3,775
Avg. Volume (20D) 10,149
Open 52.50
Previous Close 52.80
Day's Range 52.30 - 53.40
52-Week Range 37.65 - 64.40
Beta undefined

About FYB.DE

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease an...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 4, 2011
Employees 239
Stock Exchange XETRA
Ticker Symbol FYB.DE
No News article available yet